'Date-rape' drug approval raises concerns

WASHINGTON, July 18 (UPI) -- The recent approval by the Food and Drug Administration of the "date-rape" drug GHB for the treatment of a rare form of narcolepsy raises concerns among drug abuse experts that it could fall into the hands of young people wanting to use the drug for illicit purposes.